Domov › Rakovina pankreasu › North Carolina › Durham
Klinické štúdie Rakovina pankreasu v meste Durham, NC
24 štúdií pre Rakovina pankreasu hľadá účastníkov v zariadeniach v meste Durham a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
A Study of PHN-012 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- PHN-012-001 Site, Durham
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Prebieha náborFáza 3
- Duke Cancer Center, Durham
DESTINY-PANTUMOUR04
Prebieha náborObservačná štúdia
- Research Site, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Prebieha náborFáza 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 míľ odtiaľ
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 míľ odtiaľ
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Prebieha náborFáza 3
- Duke Cancer Center, Durham
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Prebieha náborFáza 3
- Investigative Site US035, Chapel Hill · 10 míľ odtiaľ
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Prebieha náborFáza 1/2
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Prebieha náborFáza 2
- Local Institution - 0100, Durham
Promoting CT Engagement for Pancreatic Cancer With App
Prebieha nábor
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Prebieha náborObservačná štúdia
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 míľ odtiaľ
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Prebieha náborFáza 2
- University of North Carolina, Chapel Hill · 10 míľ odtiaľ
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Prebieha náborFáza 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · 10 míľ odtiaľ
- University of North Carolina, Chapel Hill · 10 míľ odtiaľ
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Prebieha náborFáza 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Prebieha náborFáza 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Prebieha náborFáza 2
- Duke University Medical Center, Durham
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Prebieha náborFáza 1
- Duke Cancer Institute /ID# 276267, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Prebieha náborFáza 1
- Research Site, Durham
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Prebieha náborFáza 1
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- Duke Cancer Center, Durham
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Prebieha náborFáza 1/2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Prebieha náborFáza 2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 míľ odtiaľ
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Prebieha náborFáza 2
- University of North Carolina, Chapel Hill · 10 míľ odtiaľ
Štúdie Rakovina pankreasu v iných mestách
- Houston, TX61 štúdií
- New York City, NY60 štúdií
- Boston, MA43 štúdií
- Nashville, TN39 štúdií
- Los Angeles, CA35 štúdií
- St. Louis, MO33 štúdií
- Arlington, VA33 štúdií
- Baltimore, MD31 štúdií
- San Antonio, TX31 štúdií
- Philadelphia, PA26 štúdií
- Tampa, FL26 štúdií
- San Diego, CA24 štúdií
Iné štúdie v Durham
- Rakovina prsníka64 štúdií
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc39 štúdií
- Mnohonásobný myelóm37 štúdií
- Akútna myeloidná leukémia33 štúdií
- Metastatická rakovina33 štúdií
- Rakovina prostaty32 štúdií
- Rakovina pľúc32 štúdií
- Kolorektálny karcinóm28 štúdií
- Rakovina vaječníkov27 štúdií
- Chronická lymfocytová leukémia27 štúdií
- Srdcové zlyhanie26 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.